[
  {
    "ts": null,
    "headline": "PFIZER INC : UBS remains Neutral",
    "summary": "UBS confirms his opinion on the stock and remains Neutral. The target price remains set at USD 25.",
    "url": "https://finnhub.io/api/news?id=9696780d05e4c3206cde3acbff60f3013e552f4f9ffa72a94893e06154e7202c",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749749894,
      "headline": "PFIZER INC : UBS remains Neutral",
      "id": 135223738,
      "image": "",
      "related": "PFE",
      "source": "Finnhub",
      "summary": "UBS confirms his opinion on the stock and remains Neutral. The target price remains set at USD 25.",
      "url": "https://finnhub.io/api/news?id=9696780d05e4c3206cde3acbff60f3013e552f4f9ffa72a94893e06154e7202c"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer Pflash: A Spotlight on Pfizer's Breast Cancer Portfolio Presentation",
    "summary": "Pfizer Pflash: A Spotlight on Pfizer's Breast Cancer Portfolio June 12, 2025 1 Presentation intended for the investment community ...",
    "url": "https://finnhub.io/api/news?id=a93e362535c540e0205e4628ee70f8ffc296f960625e16c2bbbfaf27e4513dfc",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749744666,
      "headline": "Pfizer Pflash: A Spotlight on Pfizer's Breast Cancer Portfolio Presentation",
      "id": 135223226,
      "image": "",
      "related": "PFE",
      "source": "Finnhub",
      "summary": "Pfizer Pflash: A Spotlight on Pfizer's Breast Cancer Portfolio June 12, 2025 1 Presentation intended for the investment community ...",
      "url": "https://finnhub.io/api/news?id=a93e362535c540e0205e4628ee70f8ffc296f960625e16c2bbbfaf27e4513dfc"
    }
  },
  {
    "ts": null,
    "headline": "PFE's New & Acquired Drugs Hold Key to Revenue Growth Amid Headwinds",
    "summary": "PFE's new drug launches and Seagen acquisition are driving revenue gains despite COVID declines and market headwinds.",
    "url": "https://finnhub.io/api/news?id=189b973d8349840c43de0a3af184fa005ecd58de6e8dccbd304539ce3fb84b79",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749738060,
      "headline": "PFE's New & Acquired Drugs Hold Key to Revenue Growth Amid Headwinds",
      "id": 135220681,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "PFE's new drug launches and Seagen acquisition are driving revenue gains despite COVID declines and market headwinds.",
      "url": "https://finnhub.io/api/news?id=189b973d8349840c43de0a3af184fa005ecd58de6e8dccbd304539ce3fb84b79"
    }
  },
  {
    "ts": null,
    "headline": "Novavax's COVID-Flu Combo Shot Shows Strong Immune Response",
    "summary": "NVAX's COVID-flu combo shot sparks strong immunity in seniors, fueling plans for further late-stage trials.",
    "url": "https://finnhub.io/api/news?id=e112e6f6ef39c46e229cbe883e6b9f7496be4ee4eb7774808203678aebfef118",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749730500,
      "headline": "Novavax's COVID-Flu Combo Shot Shows Strong Immune Response",
      "id": 135212799,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "NVAX's COVID-flu combo shot sparks strong immunity in seniors, fueling plans for further late-stage trials.",
      "url": "https://finnhub.io/api/news?id=e112e6f6ef39c46e229cbe883e6b9f7496be4ee4eb7774808203678aebfef118"
    }
  },
  {
    "ts": null,
    "headline": "Trump Wants Cheaper Drugs Like Europe Has. How It Works.",
    "summary": "Trump Wants Cheaper Drugs Like Europe Has. How It Works.",
    "url": "https://finnhub.io/api/news?id=9f698653c1a2df4372c8b3a698e0dd3936c283e60cbe2c806d4d889e2bd8eafd",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749720060,
      "headline": "Trump Wants Cheaper Drugs Like Europe Has. How It Works.",
      "id": 135214300,
      "image": "",
      "related": "PFE",
      "source": "MarketWatch",
      "summary": "Trump Wants Cheaper Drugs Like Europe Has. How It Works.",
      "url": "https://finnhub.io/api/news?id=9f698653c1a2df4372c8b3a698e0dd3936c283e60cbe2c806d4d889e2bd8eafd"
    }
  },
  {
    "ts": null,
    "headline": "Create a Portfolio of Passive Income: 3 High-Yielding Dividend Stocks That Pay More Than 5%",
    "summary": "Dividend income offers a great way to strengthen your overall financial position.  A great way to build up dividend income is to invest in high-yielding dividend stocks that also happen to be lower-risk investments.  Pfizer (NYSE: PFE), Realty Income (NYSE: O), and Bank of Nova Scotia (NYSE: BNS) are three attractive investments that you'll want to consider if you want to create a strong portfolio of income-generating stocks.",
    "url": "https://finnhub.io/api/news?id=25c9c9f05c29003954ca371bc7ad9e03b0c3adadcf910bea778799d077b6b2bc",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749718800,
      "headline": "Create a Portfolio of Passive Income: 3 High-Yielding Dividend Stocks That Pay More Than 5%",
      "id": 135212127,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Dividend income offers a great way to strengthen your overall financial position.  A great way to build up dividend income is to invest in high-yielding dividend stocks that also happen to be lower-risk investments.  Pfizer (NYSE: PFE), Realty Income (NYSE: O), and Bank of Nova Scotia (NYSE: BNS) are three attractive investments that you'll want to consider if you want to create a strong portfolio of income-generating stocks.",
      "url": "https://finnhub.io/api/news?id=25c9c9f05c29003954ca371bc7ad9e03b0c3adadcf910bea778799d077b6b2bc"
    }
  },
  {
    "ts": null,
    "headline": "Dogs Of The S&P 500 Fetch 11 June 'Safer' Dividend Buys",
    "summary": "Analyst projections suggest the top 10 S&P 500 dividend dogs could deliver net gains of 27% to 53% by June 2026. Learn more about the dividend dogs here.",
    "url": "https://finnhub.io/api/news?id=25a03981edd57001ec6582bdfab50e555b73e78844d28ddafd0bf1ede7722543",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749700793,
      "headline": "Dogs Of The S&P 500 Fetch 11 June 'Safer' Dividend Buys",
      "id": 135209965,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1997911742/image_1997911742.jpg?io=getty-c-w1536",
      "related": "PFE",
      "source": "SeekingAlpha",
      "summary": "Analyst projections suggest the top 10 S&P 500 dividend dogs could deliver net gains of 27% to 53% by June 2026. Learn more about the dividend dogs here.",
      "url": "https://finnhub.io/api/news?id=25a03981edd57001ec6582bdfab50e555b73e78844d28ddafd0bf1ede7722543"
    }
  }
]